Eli Lilly AMAM

There’s life beyond your Crohn’s disease.

If you have moderate to severe Crohn’s disease, the VIVID-1 study may be of interest to you. This study is researching whether an investigational medication can reduce the symptoms of Crohn’s disease.

You may be able to take part if you:

  • Are between 18 and 80 years of age (inclusive)
  • Have been diagnosed with Crohn’s disease for at least three months

The study will last 1 year and 5 months. About 1,100 people from up to 36 countries around the world will participate. Study-related care will be provided at no cost

ATTENTION: This form is for information only and does not guarantee participation in any study. This form is also not meant for transmitting medical, prescription or appointment information or to initiate direct communications with our health care providers. Those inquiries should be sent through the Patient Portal or you can contact us at (612) 871-1145. Web form submissions are monitored Monday through Friday during regular business hours. In the event of a medical emergency, please dial 911.